NA Preclinical Imaging Market - Industry Trends and Forecast to 2034

NA Preclinical Imaging Market - Industry Trends and Forecast to 2034


North America preclinical imaging market is expected to reach USD 2,005,475.12 thousand by 2030, from USD 1,213,520.05 thousand in 2022 growing at the CAGR of 6.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030.

Market Segmentation
North America Preclinical Imaging Market, By Product (Systems and Services), Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, and Preclinical CT Contrast Agents), Application (Research and Development, Drug Discovery, Bio-Distribution, Cancer Cell Detection, Bio-Markers, and Others), End User (Contract Research Organization, Pharmaceutical & Biotech Companies, Academic & Government Research Institutes, Diagnostics Center, and Others), Country (U.S., Canada, and Mexico) – Industry Trends and Forecast to 2030
Overview of North America Preclinical Imaging Market Dynamics

Driver
• Increasing technology advancement in the field of imaging


Restraint

• Stringent regulatory framework for product approval


Opportunity

• Increasing adoption of imaging systems for preclinical purposes

Market Players

Some of the key market players in the North America preclinical imaging market are:

• PerkinElmer Inc.
• FUJIFILM Visualsonics, Inc (A Subsidiary of FUJIFILM Corporation)
• Bruker
• Hologic, Inc.
• ZEISS International
• Agilent Technologies, Inc.
• Hamamatsu Photonics K.K.
• SOFIE
• Cubresa Inc.
• Vieworks Co., Ltd.
• LI-COR, Inc.
• Aspect Imaging Ltd.
• Berthold Technologies GmbH & Co.KG
• MILabs B.V.
• Trifoil Imaging
• Mediso Ltd.
• IVIM Technology Inc.
• MR Solutions
• Advanced Molecular Vision, Inc.
• AI4R
• Photon etc
• KUB TECHNOLOGIES INC.


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Preclinical Imaging Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Product Segment Lifeline Curve
2.8 Market End User Coverage Grid
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
4.3 Strategic Initiatives
5 Regulatory Framework
5.1 Regulatory Scenario In U.S.
5.2 Regulatory Scenario In Australia
5.3 Regulatory Scenario In Europe
5.4 Regulatory Scenario In South Africa
5.5 Regulatory Scenario In Brazil 44 
6 Market Overview
6.1 Drivers
6.1.1 Increasing Technology Advancement In The Field Of Imaging
6.1.2 Increasing Number Of Investments And Funding In Research And Development
6.1.3 Increasing Incidence Of Chronic Diseases
6.2 Restraints
6.2.1 Stringent Regulatory Framework For Product Approval
6.2.2 High Installation And Operational Cost Of Preclinical Imaging Systems
6.3 Opportunities
6.3.1 Increasing Adoption Of Imaging Systems For Preclinical Purpose
6.3.2 Growing Demand For Non-invasive Small-animal Imaging Methods
6.4 Challenges
6.4.1 Lack Of Skilled Professionals For The Effective Utilization Of Preclinical Imaging Systems
6.4.2 Integration Of Imaging Devices With Other Technologies
7 North America Preclinical Imaging Market, By Product
7.1 Overview
7.2 Systems
7.2.1 Optical Imaging Systems
7.2.1.1 Bioluminescence/Fluorescence Imaging Systems
7.2.1.2 Standalone Fluorescence Imaging Systems
7.2.1.3 Optical + X-ray/Optical + Ct
7.2.2 Preclinical Nuclear Imaging Systems
7.2.2.1 Micro-positron Emission Tomography (Pet) Systems
7.2.2.2 Micro-single Photon Emission Computed Tomography (Spect) Systems
7.2.2.3 Triproduct (Spect/Pet/Ct) Systems
7.2.3 Micro-magnetic Resonance Imaging (Mri) Systems
7.2.4 Micro-computed Tomography (Ct) Systems
7.2.5 Micro-ultrasound Systems
7.2.6 Preclinical Photoacoustic Imaging Systems
7.2.7 Preclinical Magnetic Particle Imaging (Mpi) Systems
7.2.8 Magnetic Resonance Spectroscopy Imaging (Mrsi)
7.3 Services 59 
8 North America Preclinical Imaging Market, By Reagents
8.1 Overview
8.2 Preclinical Optical Imaging Reagents
8.2.1 Bioluminescent Imaging Reagents
8.2.2 Fluorescent Imaging Reagents
8.3 Preclinical Nuclear Imaging Reagents
8.3.1 Preclinical Pet Tracers
8.3.2 Preclinical Spect Probes
8.4 Preclinical Mri Contrast Agents
8.4.1 Gadolinium-based Preclinical Mri Contrast Agents
8.4.2 Manganese-based Preclinical Mri Contrast Agents
8.4.3 Iron-based Preclinical Mri Contrast Agents
8.5 Preclinical Ultrasound Contrast Agents
8.6 Preclinical Ct Contrast Agents
8.6.1 Iodine-based Preclinical Ct Contrast Agents
8.6.2 Barium-based Preclinical Ct Contrast Agents
8.6.3 Gold Nanoparticles
8.6.4 Gastrografin-based Preclinical Ct Contrast Agents
9 North America Preclinical Imaging Market, By Application
9.1 Overview
9.2 Research And Development
9.3 Drug Discovery
9.4 Bio-distribution
9.5 Cancer Cell Detection
9.6 Bio-markers
9.7 Others
10 North America Preclinical Imaging Market, By End User
10.1 Overview
10.2 Contract Research Organization
10.3 Pharmaceutical & Biotech Companies
10.4 Academic & Government Research Institutes
10.5 Diagnostics Center
10.6 Others 78 
11 North America Preclinical Imaging Market, By Region
11.1 North America
11.1.1 U.S.
11.1.2 Canada
11.1.3 Mexico
12 North America Preclinical Imaging Market, Company Landscape
12.1 Company Share Analysis: North America
13 Swot Analysis
14 Company Profile
14.1 Perkinelmer Inc.
14.1.1 Company Snapshot
14.1.2 Revenue Analysis
14.1.3 Company Share Analysis
14.1.4 Product Portfolio
14.1.5 Recent Development
14.2 Fujifilm Visualsonics, Inc
14.2.1 Company Snapshot
14.2.2 Revenue Analysis
14.2.3 Company Share Analysis
14.2.4 Product Portfolio
14.2.5 Recent Development
14.3 Bruker
14.3.1 Company Snapshot
14.3.2 Revenue Analysis
14.3.3 Company Share Analysis
14.3.4 Product Portfolio
14.3.5 Recent Development
14.4 Hologic, Inc.
14.4.1 Company Snapshot
14.4.2 Revenue Analysis
14.4.3 Company Share Analysis
14.4.4 Product Portfolio
14.4.5 Recent Development 125 
14.5 Zeiss International
14.5.1 Company Snapshot
14.5.2 Revenue Analysis
14.5.3 Company Share Analysis
14.5.4 Product Portfolio
14.5.5 Recent Developments
14.6 Advanced Molecular Vision, Inc.
14.6.1 Company Snapshot
14.6.2 Product Portfolio
14.6.3 Recent Developments
14.7 Agilent Technologies, Inc.
14.7.1 Company Snapshot
14.7.2 Revenue Analysis
14.7.3 Product Portfolio
14.7.4 Recent Development
14.8 Ai4r
14.8.1 Company Snapshot
14.8.2 Product Portfolio
14.8.3 Recent Development
14.9 Aspect Imaging Ltd.
14.9.1 Company Snapshot
14.9.2 Product Portfolio
14.9.3 Recent Development
14.10 Berthold Technologies Gmbh & Co.Kg
14.10.1 Company Snapshot
14.10.2 Product Portfolio
14.10.3 Recent Development
14.11 Cubresa Inc.
14.11.1 Company Snapshot
14.11.2 Product Portfolio
14.11.3 Recent Development
14.12 Hamamatsu Photonics K.K.
14.12.1 Company Snapshot
14.12.2 Revenue Analysis
14.12.3 Product Portfolio
14.12.4 Recent Development
14.13 Ivim Technology Corp.
14.13.1 Company Snapshot
14.13.2 Product Portfolio
14.13.3 Recent Development
14.14 Kub Technologes Inc.
14.14.1 Company Snapshot
14.14.2 Product Portfolio
14.14.3 Recent Development
14.15 Li-cor, Inc.
14.15.1 Company Snapshot
14.15.2 Product Portfolio
14.15.3 Recent Development
14.16 Mediso Ltd.
14.16.1 Company Snapshot
14.16.2 Product Portfolio
14.16.3 Recent Development
14.17 Milabs B.V.
14.17.1 Company Snapshot
14.17.2 Product Portfolio
14.17.3 Recent Development
14.18 Mr Solutions
14.18.1 Company Snapshot
14.18.2 Product Portfolio
14.18.3 Recent Development
14.19 Photon Etc
14.19.1 Company Snapshot
14.19.2 Product Portfolio
14.19.3 Recent Development
14.20 Sofie
14.20.1 Company Snapshot
14.20.2 Product Portfolio
14.20.3 Recent Development
14.21 Trifoil Imaging
14.21.1 Company Snapshot
14.21.2 Product Portfolio
14.21.3 Recent Development
14.22 Vieworks Co., Ltd.
14.22.1 Company Snapshot
14.22.2 Revenue Analysis
14.22.3 Product Portfolio
14.22.4 Recent Development
15 Questionnaire
16 Related Reports
List Of Tables
Table 1 North America Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 2 North America Systems In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 3 North America Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 4 North America Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 5 North America Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 6 North America Services In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 7 North America Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 8 North America Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 9 North America Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 10 North America Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 11 North America Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 12 North America Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 13 North America Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 14 North America Preclinical Ultrasound Contrast Agents In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 15 North America Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 16 North America Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 17 North America Preclinical Imaging Market, By Application, 2021-2030 (Usd Thousand)
Table 18 North America Research And Development In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 19 North America Drug Discovery In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 20 North America Bio-distribution In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 21 North America Cancer Cell Detection In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 22 North America Bio-markers In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 23 North America Others In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 24 North America Preclinical Imaging Market, By End User, 2021-2030 (Usd Thousand)
Table 25 North America Contract Research Organization In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 26 North America Pharmaceutical & Biotech Companies In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 27 North America Academic & Government Research Institutes In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 28 North America Diagnostics Center In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 29 North America Others In Preclinical Imaging Market, By Region, 2021-2030 (Usd Thousand)
Table 30 North America Preclinical Imaging Market, By Country, 2021-2030 (Usd Thousand)
Table 31 North America Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 32 North America Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 33 North America Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 34 North America Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 35 North America Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 36 North America Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 37 North America Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 38 North America Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 39 North America Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 40 North America Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 41 North America Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 42 North America Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 43 North America Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 44 North America Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 45 North America Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 46 North America Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 47 North America Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 48 North America Preclinical Imaging Market, By Application, 2021-2030 (Usd Thousand)
Table 49 North America Preclinical Imaging Market, By End User, 2021-2030 (Usd Thousand)
Table 50 U.S. Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 51 U.S. Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 52 U.S. Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 53 U.S. Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 54 U.S. Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 55 U.S. Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 56 U.S. Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 57 U.S. Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 58 U.S. Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 59 U.S. Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 60 U.S. Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 61 U.S. Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 62 U.S. Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 63 U.S. Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 64 U.S. Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 65 U.S. Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 66 U.S. Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 67 U.S. Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 68 U.S. Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 69 U.S. Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 70 U.S. Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 71 U.S. Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 72 U.S. Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 73 U.S. Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 74 U.S. Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 75 U.S. Preclinical Imaging Market, By Application, 2021-2030 (Usd Thousand)
Table 76 U.S. Preclinical Imaging Market, By End User, 2021-2030 (Usd Thousand)
Table 77 Canada Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 78 Canada Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 79 Canada Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 80 Canada Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 81 Canada Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 82 Canada Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 83 Canada Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 84 Canada Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 85 Canada Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 86 Canada Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 87 Canada Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 88 Canada Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 89 Canada Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 90 Canada Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 91 Canada Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 92 Canada Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 93 Canada Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 94 Canada Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 95 Canada Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 96 Canada Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 97 Canada Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 98 Canada Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 99 Canada Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 100 Canada Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 101 Canada Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 102 Canada Preclinical Imaging Market, By Application, 2021-2030 (Usd Thousand)
Table 103 Canada Preclinical Imaging Market, By End User, 2021-2030 (Usd Thousand)
Table 104 Mexico Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 105 Mexico Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 106 Mexico Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 107 Mexico Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 108 Mexico Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 109 Mexico Optical Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 110 Mexico Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Usd Thousand)
Table 111 Mexico Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Volume)
Table 112 Mexico Preclinical Nuclear Imaging Systems In Preclinical Imaging Market, By Product, 2021-2030 (Asp)
Table 113 Mexico Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 114 Mexico Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 115 Mexico Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 116 Mexico Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 117 Mexico Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 118 Mexico Preclinical Optical Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 119 Mexico Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 120 Mexico Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 121 Mexico Preclinical Nuclear Imaging Reagents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 122 Mexico Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 123 Mexico Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 124 Mexico Preclinical Mri Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 125 Mexico Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Usd Thousand)
Table 126 Mexico Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Volume)
Table 127 Mexico Preclinical Ct Contrast Agents In Preclinical Imaging Market, By Reagents, 2021-2030 (Asp)
Table 128 Mexico Preclinical Imaging Market, By Application, 2021-2030 (Usd Thousand)
Table 129 Mexico Preclinical Imaging Market, By End User, 2021-2030 (Usd Thousand)
List Of Figures
Figure 1 North America Preclinical Imaging Market: Segmentation
Figure 2 North America Preclinical Imaging Market: Data Triangulation
Figure 3 North America Preclinical Imaging Market: Droc Analysis
Figure 4 North America Preclinical Imaging Market: North America Vs Regional Market Analysis
Figure 5 North America Preclinical Imaging Market: Company Research Analysis
Figure 6 North America Preclinical Imaging Market: Interview Demographics
Figure 7 North America Preclinical Imaging Market: Market End Users Coverage Grid
Figure 8 North America Preclinical Imaging Market: Dbmr Market Position Grid
Figure 9 North America Preclinical Imaging Market: Vendor Share Analysis
Figure 10 North America Preclinical Imaging Market: Segmentation
Figure 11 Rising Prevalence Of Chronic Disorder And Advancements In Imaging Techniques Are Expected To Drive The Growth Of The North America Preclinical Imaging Market From 2023 To 2030
Figure 12 Systems Segment Is Expected To Account For The Largest Share Of The North America Preclinical Market In 2023 And 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Preclinical Imaging Market
Figure 14 North America Preclinical Imaging Market: By Product, 2022
Figure 15 North America Preclinical Imaging Market: By Reagents, 2022
Figure 16 North America Preclinical Imaging Market: By Application, 2022
Figure 17 North America Preclinical Imaging Market: By End User, 2022
Figure 18 North America Preclinical Imaging Market: Company Share 2022 (%)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings